Bleomycin ( DrugBank: Bleomycin )

---

4 diseases

ID	Disease name (Link within this page)	Number of trials
96	Crohn disease	1
278	Huge lymphatic malformation with cervicofacial lesion	1
279	Huge venous malformation with cervical, oral and pharyngeal diffuse lesion	2
280	Huge arteriovenous malformation with cervicofacial or limb lesion	2

96. Crohn disease

---

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

278. Huge lymphatic malformation with cervicofacial lesion

---

Clinical trials : 19 / Drugs : 22 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 63 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion

---

Clinical trials : 15 / Drugs : 24 - (DrugBank : 10) / Drug target genes : 3 - Drug target pathways : 105 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

280. Huge arteriovenous malformation with cervicofacial or limb lesion

---

Clinical trials : 27 / Drugs : 30 - (DrugBank : 15) / Drug target genes : 14 - Drug target pathways : 153 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries